SET Announcements
The latest company disclosures have been updated, offering investors and stakeholders timely access to essential information.
14 May 2025
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025
14 May 2025
Financial Performance Quarter 1 (F45) (Reviewed)
14 May 2025
Financial Statement Quarter 1/2025 (Reviewed)
18 April 2025
Publication of the Minutes of the 2025 Annual General Meeting of Shareholders on the Company's Website
04 April 2025
Notification of the Resolutions of the 2025 Annual General Meeting of Shareholders
31 March 2025
Mega Lifesciences Public Company Limited ("MEGA") confirms that there is no impact of earthquake on its employees, assets and business continuity. (revised version)
31 March 2025
Mega Lifesciences Public Company Limited ("MEGA") confirms that there is no impact of earthquake on its employees, assets and business continuity.
28 February 2025
Publication of the Invitation to the 2025 Annual General Meeting of Shareholders
25 February 2025
Resolutions of the Board of Directors' meeting regarding the dividend payment proposal for the year ended December 31, 2024, and the date and agenda items of the Annual General Meeting of Shareholders of 2025 (the "Meeting") (Revised)
24 February 2025
Resolutions of the Board of Directors' meeting regarding the dividend payment proposal for the year ended December 31, 2024, and the date and agenda items of the Annual General Meeting of Shareholders of 2025 (the "Meeting")
24 February 2025
Management Discussion and Analysis Yearly Ending 31 Dec 2024
24 February 2025
